biotech · Generalized Myasthenia Gravis · Leukemia, Myeloid, Acute · VOR
Vor Biopharma
Vor Biopharma patent portfolio — 12 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Employees
- 110
- Programs
- 6
- Drugs
- 4
- Patents
- 12
Vor Biopharma patents
12 pharmaceutical patents indexed for Vor Biopharma. 0 expire within 24 months.
Vor Biopharma has 12 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12403200
Methods and compositions for treating autoimmune diseases
granted -
US 12291576
Anti-CD45 antibodies and conjugates thereof
granted -
US 12251403
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 12209135
Anti-CD45 antibodies and conjugates thereof
granted -
US 11975029
Compositions and methods for inhibition of lineage specific proteins
granted -
US 11903973
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11571445
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11559551
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11464807
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11389485
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11382932
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 10925902
Genetically engineered hematopoietic stem cells and uses thereof
granted
Frequently asked questions
How many patents does Vor Biopharma have?
12 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Vor Biopharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.